AVODART DUTASTERIDE & PROSTATE CANCER PREVENTION Because most prostate cancers, like breast cancer, are fueled by sex hormones, the prevention of prostate cancer through the use of hormone-blocking me...
Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong survival significantly, according
An experimental drug from Germany's Bayer and Norwegian biotech Algeta that prolongs the lives of patients with advanced prostate cancer is a major step forward in treatment of the disease
AMSTERDAM, Sept. 26, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ:ITMN) today reported that new data(1) was presented at the European Respiratory Society (ERS) Annual Congress supporting the longer-term safety and tolerability of Esbriet® (pirfenidone) i
Novartis International AG / New Novartis data show potential of respiratory portfolio to help COPD patients maintain active and productive lives . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content …
At the European Respiratory Society (ERS) congress in Amsterdam, Novartis presented new Phase III data and demonstrated the potential of their new once-daily inhaled treatments for individuals suffering with COPD, which helps patients to maintain more act